Influence of HCV genotype 1 subtypes on the virus response to PEG interferon alpha-2a plus ribavirin therapy. (Record no. 20545597)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01997 a2200673 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250516022113.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201112s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1096-9071 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1002/jmv.21976 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Nicot, F |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20111216 |
| 245 00 - TITLE STATEMENT | |
| Title | Influence of HCV genotype 1 subtypes on the virus response to PEG interferon alpha-2a plus ribavirin therapy. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Journal of medical virology |
| Date of publication, distribution, etc. | Mar 2011 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 437-44 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antiviral Agents |
| General subdivision | blood |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Therapy, Combination |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Genotype |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | HIV Infections |
| General subdivision | complications |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Hepacivirus |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Hepatitis C, Chronic |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Interferon-alpha |
| General subdivision | blood |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Polyethylene Glycols |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Prospective Studies |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Recombinant Proteins |
| General subdivision | blood |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Ribavirin |
| General subdivision | blood |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Treatment Outcome |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Viral Load |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Alric, L |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Barange, K |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Métivier, S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dramard, J M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Combis, J M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Castan, B |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Meurisse, J J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Payen, J L |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Garipuy, D |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Desmorat, H |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Peron, J M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Thebault, S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Morin, T |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Renou, C |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Barel, P |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Guerin, B |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Imbert, Y |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sire, S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sauné, K |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Chatelut, E |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Izopet, J |
| 773 0# - HOST ITEM ENTRY | |
| Title | Journal of medical virology |
| Related parts | vol. 83 |
| -- | no. 3 |
| -- | p. 437-44 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1002/jmv.21976">https://doi.org/10.1002/jmv.21976</a> |
| Public note | Available from publisher's website |
No items available.